CYBN Cybin | $0.27
| 5/2/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $3.63
-4.5% | 4/19/2024 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
FUSN Fusion Pharmaceuticals | $21.55
| 3/20/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/20/2024 |
RPTX Repare Therapeutics | $3.63
-4.5% | 2/13/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
FUSN Fusion Pharmaceuticals | $21.55
| 1/5/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/5/2024 |
MBX Microbix Biosystems | C$0.32
-3.0% | 1/4/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
|
ABCL AbCellera Biologics | $3.02
-1.3% | 11/3/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$1.63
+3.8% | 6/26/2023 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
OPS Opsens | C$2.90
| 3/28/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Opsens (TSE:OPS) on 3/28/2023 |
RX BioSyent | C$9.60
+0.9% | 3/23/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
DOC CloudMD Software & Services | C$0.04
+16.7% | 11/16/2022 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
DOC CloudMD Software & Services | C$0.04
+16.7% | 8/24/2022 | Downgraded by | Bloom Burton | Analyst P. Pandurangan | Buy -> Hold | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
MDNA Medicenna Therapeutics | C$1.83
-4.7% | 8/16/2022 | Target Lowered by | Bloom Burton | - | Buy | C$9.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$1.83
-4.7% | 7/28/2022 | Reiterated by | Bloom Burton | - | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$3.35
+1.5% | 7/26/2022 | Reiterated by | Bloom Burton | - | Buy | C$22.00 | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.32
-3.0% | 6/6/2022 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
GUD Knight Therapeutics | C$5.43
-1.3% | 3/28/2022 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | C$6.70 | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$5.43
-1.3% | 3/25/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$9.60
+0.9% | 3/10/2022 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.04
+16.7% | 12/22/2021 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Buy | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $3.02
-1.3% | 12/19/2021 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | $23.00 | Medium | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $3.63
-4.5% | 9/30/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | $49.00 | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$1.83
-4.7% | 9/22/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
BLU BELLUS Health | C$19.48
-0.1% | 8/13/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/13/2021 |
HLS HLS Therapeutics | C$3.35
+1.5% | 8/5/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $6.61
-3.6% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
AUP Aurinia Pharmaceuticals | C$16.76
-3.5% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 5/7/2021 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | High | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$5.43
-1.3% | 3/26/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$9.60
+0.9% | 3/18/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$7.75
-4.9% | 2/23/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $4.66
-4.9% | 2/12/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold | $3.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRHM CRH Medical | $3.99
| 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
FUSN Fusion Pharmaceuticals | $21.55
| 12/17/2020 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Medium | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 12/17/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUP Aurinia Pharmaceuticals | C$16.76
-3.5% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 11/3/2020 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $6.61
-3.6% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | High | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
The asset beating inflation by 4x (Ad) Central Bank Gold Heist In Progress
Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too. Click here to get your free copy today. |
RPTX Repare Therapeutics | $3.63
-4.5% | 9/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45
+4.3% | 8/21/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $36.25
-1.0% | 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $25.00 | Medium | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $77.85
-1.1% | 8/14/2020 | Reiterated by | Bloom Burton | - | Buy | | Low | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $4.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
CRHM CRH Medical | $3.99
| 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
HLS HLS Therapeutics | C$3.35
+1.5% | 7/21/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
GUD Knight Therapeutics | C$5.43
-1.3% | 6/29/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $8.52
-0.2% | 6/14/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $4.66
-4.9% | 5/24/2020 | Reiterated by | Bloom Burton | - | Buy | $9.00 | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 5/8/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$3.35
+1.5% | 3/31/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$9.60
+0.9% | 3/19/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 3/19/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $23.00 | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
COM 138267 (COM.TO) | C$2.95
-2.6% | 12/13/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Sell -> Hold | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 12/13/2019 |
COM 138267 (COM.TO) | C$2.95
-2.6% | 12/6/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 12/6/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/12/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$5.43
-1.3% | 10/22/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$3.35
+1.5% | 10/4/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUP Aurinia Pharmaceuticals | C$16.76
-3.5% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 10/2/2019 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$9.60
+0.9% | 8/26/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 8/12/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$3.35
+1.5% | 8/9/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
BLU BELLUS Health | C$19.48
-0.1% | 8/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$7.75
-4.9% | 7/3/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/16/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 4/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$3.35
+1.5% | 3/22/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 3/20/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06
| 3/15/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | Low | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$5.43
-1.3% | 11/9/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
BLU BELLUS Health | C$19.48
-0.1% | 7/6/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 7/6/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 3/26/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$9.60
+0.9% | 3/22/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
EPI ESSA Pharma | C$8.20
+7.2% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $4.66
-4.9% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/3/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45
+4.3% | 10/25/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
EPIX ESSA Pharma | $4.66
-4.9% | 9/12/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 8/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $4.66
-4.9% | 5/18/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/15/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 5/12/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/9/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
BLU BELLUS Health | C$19.48
-0.1% | 3/1/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 3/1/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$9.60
+0.9% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
Kiss of death from Joe Biden (Ad) Biden cannot lose this election.
A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election. I have uncovered a bombshell that changes everything… and threatens everything. |
CPH Cipher Pharmaceuticals | C$8.31
-0.2% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 1/9/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $36.25
-1.0% | 12/22/2016 | Initiated by | Bloom Burton | - | Buy | $14.50 | N/A | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.01
-1.6% | 12/14/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$5.43
-1.3% | 11/10/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
COM 138267 (COM.TO) | C$2.95
-2.6% | 11/9/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 11/9/2016 |
AUP Aurinia Pharmaceuticals | C$16.76
-3.5% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 11/4/2016 |
AUPH Aurinia Pharmaceuticals | $5.42
-2.2% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/2/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
ACHV Achieve Life Sciences | $4.78
-4.0% | 5/3/2013 | Target Raised by | Bloom Burton | - | Buy | $4,000.00 -> $5,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $4.78
-4.0% | 3/8/2013 | Target Raised by | Bloom Burton | - | | $3,600.00 -> $4,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$1.39
| 12/18/2012 | Downgraded by | Bloom Burton | - | Buy -> Hold | | N/A | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
THTX Theratechnologies | $1.32
+2.3% | 6/25/2012 | Downgraded by | Bloom Burton | - | Hold -> Sell | $2.50 -> $0.75 | N/A | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
ACHV Achieve Life Sciences | $4.78
-4.0% | 5/4/2012 | Target Lowered by | Bloom Burton | - | Buy | $3,800.00 -> $3,600.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |
